Skip to main content

Breast and Gynecologic Cancers

Conducts and fosters research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and related precursor conditions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Diabetes Prevention Program Outcomes Study (DPPOS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Altshuler, Rachel, Ph.D. rachel.altshuler@nih.gov 240-276-5873	5E304	Program Officer \| Breast and Gynecologic Cancer
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	Brofsky, Emma, M.S.P.H. emma.brofsky@nih.gov 240-276-7532	5E314	Program Analyst \| Breast and Gynecologic Cancer
	Dimond, Eileen, R.N., M.S. eileen.dimond@nih.gov 240-276-7086	5E332	Nurse Consultant \| Breast and Gynecologic Cancer
	Frech, Maria Silvina, Ph.D., M.S. maria.frech@nih.gov 240-276-5302	5E320	Program Officer \| Breast and Gynecologic Cancer
	Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048	5E334	Chief \| Breast and Gynecologic Cancer Acting Chief \| Community Oncology and Prevention Trials
	Perloff, Marjorie, M.D. marjorie.perloff@nih.gov 240-276-7097	5E544	Program Officer \| Breast and Gynecologic Cancer
	Rubinstein, Wendy, M.D., Ph.D. wendy.rubinstein@nih.gov	5E436	Program Officer \| Breast and Gynecologic Cancer
	Sahasrabuddhe, Vikrant, M.B.B.S., M.P.H., Dr.P.H. vikrant.sahasrabuddhe@nih.gov 240-276-7332	5E444	Deputy Chief \| Breast and Gynecologic Cancer
	Samimi, Goli, Ph.D., M.P.H. goli.samimi@nih.gov 240-276-6582	5E336	Program Officer \| Breast and Gynecologic Cancer
	Sauter, Edward, M.D., Ph.D. edward.sauter@nih.gov 240-276-7657	5E338	Program Officer \| Breast and Gynecologic Cancer
	Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050	5E430	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163	5E524	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	Wood (Gunn), Kristen, B.S.N. kristen.gunn@nih.gov	5E326	Nurse Consultant \| Breast and Gynecologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Hecht, Stephen S	University Of Minnesota United States	High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck	5R01CA263084-05	Wendy Wang, Ph.D., M.Sc.
Heine, John J	H. Lee Moffitt Cancer Ctr & Res Inst United States	Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center	5U01CA200464-08	Guillermo Marquez, Ph.D.
Herman, James G.	University Of Pittsburgh At Pittsburgh United States	Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies	5U2CCA271885-04	Wendy Wang, Ph.D., M.Sc.
Herrmann, Joerg	Mayo Clinic Rochester United States	TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial	5R01CA233610-06	Eileen Dimond, R.N., M.S.
Hilakivi-Clarke, Leena A.	University Of Minnesota United States	Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota	5R01CA276775-03	Amit Kumar, Ph.D.
Hill, Joshua Aiden	Fred Hutchinson Cancer Center United States	Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy	5R01CA276040-03	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Hitchins, Megan P	H. Lee Moffitt Cancer Ctr & Res Inst United States	Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age	7R01CA252042-05	Matthew Young, Ph.D.
Hollingsworth, Michael A.	University Of Nebraska Medical Center United States	Pancreatic Cancer Detection Consortium	5U01CA210240-09	Matthew Young, Ph.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis	4U01CA288375-03	Sidney Fu, M.D.
Houghton, A Mcgarry	Fred Hutchinson Cancer Center United States	Tumor-specific autoantibodies for SCLC early detection	5R01CA243328-06	Guillermo Marquez, Ph.D.
Howitt, Brooke E	Stanford University United States	Unraveling heterogeneity in endometrial cancer via integrated single cell genotype-phenotype mapping	1R37CA303960-01	Goli Samimi, Ph.D., M.P.H.
Hruska, Carrie B	Mayo Clinic Rochester United States	Density MATTERS Clinical Trial	5R01CA239200-05	Claire Zhu, Ph.D.
Hsu, Li	Fred Hutchinson Cancer Center United States	Statistical Methods for Precision Prevention	1R01CA297681-01	Claire Zhu, Ph.D.
Hu, Shuiying	Ohio State University United States	Targeting neuronal transport to ameliorate vincristine neurotoxicity	5R01CA272254-03	Rachel Altshuler, Ph.D.
Hu, Jim	Weill Medical Coll Of Cornell Univ United States	Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)	5R01CA259173-04	Marjorie Perloff, M.D.